These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 874507)

  • 41. Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
    Reubi JC; Iversen LL; Jessell TM
    Nature; 1977 Aug; 268(5621):652-4. PubMed ID: 197423
    [No Abstract]   [Full Text] [Related]  

  • 42. Topographical study of the distribution of gamma-aminobutyric acid (GABA) in the human substantia nigra. A case study.
    Kanazawa I; Toyokura Y
    Brain Res; 1975 Dec; 100(2):371-81. PubMed ID: 1192182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex difference in the turnover of GABA in the rat substantia nigra.
    Manev H; Pericić D
    J Neural Transm; 1987; 70(3-4):321-8. PubMed ID: 3681288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
    Koob G; del Fiacco M; Iversen SD
    Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
    [No Abstract]   [Full Text] [Related]  

  • 45. GABA-mimetic compounds block haloperidol-induced hyperprolactinemia in rats.
    Debeljuk L; Torres Alemán I
    Adv Biochem Psychopharmacol; 1986; 42():139-44. PubMed ID: 3766216
    [No Abstract]   [Full Text] [Related]  

  • 46. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 48. High affinity uptake of GABA in presumed GABA-ERGIC nerve endings in rat brain.
    Storm-Mathisen J
    Brain Res; 1975 Feb; 84(3):409-27. PubMed ID: 1122379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Picrotoxin convulsions and GABA metabolism after injection of anticonvulsants in chicks.
    Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Eur J Pharmacol; 1976 Nov; 40(1):101-6. PubMed ID: 991920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity.
    Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F
    Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172
    [No Abstract]   [Full Text] [Related]  

  • 51. Striatal dopamine and gamma-hydroxybutyrate.
    Roth RH
    Pharmacol Ther B; 1976; 2(1):71-88. PubMed ID: 817333
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 54. GABA as a transmitter in the central nervous system of vertebrates.
    Storm-Mathisen J
    J Neural Transm; 1974; Suppl 11(0):227-53. PubMed ID: 4153542
    [No Abstract]   [Full Text] [Related]  

  • 55. Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Br J Pharmacol; 1975 Oct; 55(2):288P. PubMed ID: 1238134
    [No Abstract]   [Full Text] [Related]  

  • 56. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection.
    Nagy JI; Carter DA; Fibiger HC
    Brain Res; 1978 Dec; 158(1):15-29. PubMed ID: 21348349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.
    Jung MJ; Lippert B; Metcalf BW; Schechter PJ; Böhlen P; Sjoerdsma A
    J Neurochem; 1977 Apr; 28(4):717-23. PubMed ID: 894280
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for the involvement of nigrothalamic GABA neurons in circling behaviour in the rat.
    Kilpatrick IC; Starr MS; James TA; MacLeod NK
    Adv Biochem Psychopharmacol; 1981; 30():205-24. PubMed ID: 7331935
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of benzene vapour on the gamma-aminobutyric acid (GABA) system in rat brain.
    Kadyrov GK; Saforov MI; Sytinsky IA
    Biochem Pharmacol; 1975 Nov; 24(22):2083-7. PubMed ID: 1212255
    [No Abstract]   [Full Text] [Related]  

  • 60. Regional distribution of glutamate decarboxylase and gaba within the amygdaloid complex and stria terminalis system of the rat.
    Ben-Ari Y; Kanazawa I; Zigmond RE
    J Neurochem; 1976 Jun; 26(6):1279-83. PubMed ID: 932733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.